S&P 500 7,667 +3.20% Nasdaq 26,284 +5.66% Dow Jones 53,814 +2.02% FTSE 100 10,886 +0.14% DAX 26,186 +2.84% Nikkei 225 63,958 +4.11% Hang Seng 25,853 +2.14% WTI Crude 75.96 -9.13% Gold 4,148 +1.16% US 10-Year Treasury Yield 4.637 +0.32% S&P 500 7,667 +3.20% Nasdaq 26,284 +5.66% Dow Jones 53,814 +2.02% FTSE 100 10,886 +0.14% DAX 26,186 +2.84% Nikkei 225 63,958 +4.11% Hang Seng 25,853 +2.14% WTI Crude 75.96 -9.13% Gold 4,148 +1.16% US 10-Year Treasury Yield 4.637 +0.32%

LATEST

Naval shipbuilding attracts private equity; Sheridan acquires Carolina Components; KKR to take Integer Holdings private for $5.7bn●BP Retreats Further From Green Energy With Archaea Sale●Dinari brings tokenized U.S. stocks to American investors as equity race heats up●Institutional investors over subscribe LIC OFS, bid ₹36,400 crore, retail offer in 6.5% stake sale begins tomorrow●AMD earnings are a key test for chips and momentum stocks. Here's what the options market is saying●Your Lagos food basket in July: What got cheaper, what didn’t●FG orders MDAs to comply with data protection law, warns accounting officers of liability●The Smartest Growth ETF to Buy Right Now -- and It's Up 50% in 2026●Naval shipbuilding attracts private equity; Sheridan acquires Carolina Components; KKR to take Integer Holdings private for $5.7bn●BP Retreats Further From Green Energy With Archaea Sale●Dinari brings tokenized U.S. stocks to American investors as equity race heats up●Institutional investors over subscribe LIC OFS, bid ₹36,400 crore, retail offer in 6.5% stake sale begins tomorrow●AMD earnings are a key test for chips and momentum stocks. Here's what the options market is saying●Your Lagos food basket in July: What got cheaper, what didn’t●FG orders MDAs to comply with data protection law, warns accounting officers of liability●The Smartest Growth ETF to Buy Right Now -- and It's Up 50% in 2026●

Front Page

Could Revolution Medicines (RVMD) Become a $20 Billion Cancer Drug Story?

Yahoo Finance · 1h ago

Could Revolution Medicines (RVMD) Become a $20 Billion Cancer Drug Story?

Read the full story at Yahoo Finance →

More Front Page

AMD earnings are a key test for chips and momentum stocks. Here's what the options market is saying

US Top News and Analysis · 31m ago

The Smartest Growth ETF to Buy Right Now -- and It's Up 50% in 2026

Yahoo Finance · 37m ago

Huntington Ingalls (HII) Q2 2026 Earnings Call Transcript

Yahoo Finance · 37m ago

Baron Capital Sees Years of Mid-Teens Growth for Intuitive Surgical (ISRG)

Yahoo Finance · 41m ago